No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients

Alexa Podolsky; Shari Lipner

doi:10.5826/dpc.1601a6430

No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients

Authors

Alexa Podolsky Renaissance School of Medicine, Stony Brook University, New York, USA. https://orcid.org/0009-0008-6954-992X
Shari Lipner Department of Dermatology, Weill Cornell Medicine, New York, USA. https://orcid.org/0000-0001-5913-9304

Keywords:

minoxidil, alopecia, hair loss

References

Gupta AK, Talukder M, Shemer A, Piraccini BM, Tosti A. Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review. Skin Appendage Disord. 2023;9(6):423-437. DOI:10.1159/000531890. PMID: 38376087; PMCID: PMC10806356.

Ong MM, Do H, Ho B, Lipner SR. Gender Differences in Adverse Effects and Dosing Practices of Low-Dose Oral Minoxidil for Androgenetic Alopecia: A Retrospective Analysis of 310 Patients. Skin Appendage Disord. 2025;11(3):227-231. DOI:10.1159/000542630. PMID: 40475096; PMCID: PMC12136553.

Sanabria B, Vanzela TN, Miot HA, Müller Ramos P. Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. J Am Acad Dermatol. 2021;84(4):1175-1178. DOI:10.1016/j.jaad.2020.11.035. PMID: 33253848.

Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. DOI:10.1016/j.jaad.2021.02.054. PMID: 33639244.

Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. DOI:10.1001/jamadermatol.2024.0284. PMID: 38598226; PMCID: PMC11007651.